Earnings Call · Q2 FY2021·2021-08-08

Q2 21EPS -18.81%·Rev n/aQ1 21EPS -7.50%·Rev n/aQ4 20EPS -21.43%·Rev n/aQ3 20EPS +5.62%·Rev n/a⚠ consensus missing

Passage BIO, Inc. PASG

Stuart Henderson — Investor Relations or Communications

Bruce Goldsmith — President and Chief Executive Officer

Eliseo Salinas — Chief Medical Officer or Senior Medical Executive

+5.8%1d on move date+5.1% vs SPY3d+3.4%5d+1.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PASG calls or request research access.

More PASG calls Browse calls Request research access